🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Benjamin Speich

University of Basel

ORCID: 0000-0002-3301-8085

Also affiliated with University Hospital of Basel

Decision SciencesMedicineImmunology and MicrobiologyVeterinary

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 4%percentile
0.899Author DataRank

Indexed papers

1in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology
Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Top data-sharing exemplar

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

The Comparative Effectiveness of Innovative Treatments for Cancer (CEIT-Cancer) project: Rationale and design of the database and the collection of evidence available at approval of novel drugs

Trials(2018)10.1186/s13063-018-2877-z
Top 22%
0.899DataRank
Top 22%23 citations

Benjamin Speich, Florian Naudet, Arnav Agarwal, Francesco Sclafani, Juan Martin-Liberal +9 more

Papers

Driven by 9 papers — median percentile 78. Top paper: “Clinical Trial Evidence Supporting US Food and Drug Administration Approval of Novel Cancer Therapies Between 2000 and 2016”.

Clinical Trial Evidence Supporting US Food and Drug Administration Approval of Novel Cancer Therapies Between 2000 and 2016

JAMA Network Open(2020)10.1001/jamanetworkopen.2020.24406
N/A
4.3DataRank · unranked
97 citations

Andreas M. Schmitt, Benjamin Speich, Florian Naudet, Arnav Agarwal, Tiago V. Pereira +12 more

The Comparative Effectiveness of Innovative Treatments for Cancer (CEIT-Cancer) project: Rationale and design of the database and the collection of evidence available at approval of novel drugs

Trials(2018)10.1186/s13063-018-2877-z
Top 22%
0.899DataRank
Top 22%23 citations

Benjamin Speich, Florian Naudet, Arnav Agarwal, Francesco Sclafani, Juan Martin-Liberal +9 more

Single pivotal trials with few corroborating characteristics were used for FDA approval of cancer therapies

Journal of Clinical Epidemiology(2019)10.1016/j.jclinepi.2019.05.033
N/A
0.477DataRank · unranked
23 citations

Benjamin Speich, Matthias Briel, Francesco Sclafani, Heiner C. Bucher, Arnav Agarwal +5 more

Marginal structural models and other analyses allow multiple estimates of treatment effects in randomized clinical trials: Meta-epidemiological analysis

Journal of Clinical Epidemiology(2019)10.1016/j.jclinepi.2018.11.001
N/A
0.373DataRank · unranked
11 citations

Benjamin Speich, Aviv Ladanie, Heiner C. Bucher, Lars G. Hemkens, John P. A. Ioannidis +1 more

Antibody and T-Cell Response to Bivalent Booster SARS-CoV-2 Vaccines in People With Compromised Immune Function: COVERALL-3 Study

The Journal of Infectious Diseases(2024)10.1093/infdis/jiae291
N/A
0.165DataRank · unranked
2 citations

Frédérique Chammartin, Annette Audigé, Anna Eichenberger, Dominique L. Braun, Patrizia Amico +84 more

Low agreement and frequent invalid controls in two SARS-CoV-2 T-cell assays in people with compromised immune function

PLoS ONE(2025)10.1371/journal.pone.0317965
N/A
0DataRank · unranked
0 citations

Alain Amstutz, Macé M. Schuurmans, Patrizia Amico, Dominique L. Braun, Marcel Stoeckle +21 more

Effects of remdesivir in patients hospitalised with COVID-19: a systematic review and individual patient data meta-analysis of randomised controlled trials

The Lancet Respiratory Medicine(2023)10.1016/s2213-2600(22)00528-8
N/A
0DataRank · unranked
125 citations

Benjamin Speich, France Mentré, Corina S. Rueegg, Drifa Belhadi, Lambert Assoumou +30 more

Antibody Response After Third Vaccination With mRNA-1273 or BNT162b2: Extension of a Randomized Controlled SARS-CoV-2 Noninferiority Vaccine Trial in Patients With Different Levels of Immunosuppression (COVERALL-2)

Open Forum Infectious Diseases(2023)10.1093/ofid/ofad150
N/A
0DataRank · unranked
9 citations

Frédérique Chammartin, Irène A. Abela, Patrizia Amico, Marcel Stoeckle, Anna Eichenberger +85 more

Prediction of RECRUITment In randomized clinical Trials (RECRUIT-IT)-rationale and design for an international collaborative study [study protocol].

BORIS (University Library Bern)(2020)10.7892/boris.146085
N/A
0DataRank · unranked
0 citations

Junhao Liu, Yu Jiang, Byron J. Gajewski, Cen Wu, Erik von Elm +20 more